News

BioNTech to buy former Boston Covid vaccine rival for $1.25B
BioNTech SE is acquiring a Boston biotech that just a few years ago sued the German company for Covid-19 patent violations.
In Vitro Diagnostic Quality Control Market Research 2025: Biotechnology Boom Propels Clinical Laboratory Testing Growth, Especially In Genomics
Explore booming opportunities in the recession-proof IVD Quality Control industry with our detailed report. Discover how new technology and genomic a ...
Cytokinetics, Incorporated (CYTK) Price Target Lowered To $53 from $71 at JPMorgan
Cytokinetics, Incorporated (NASDAQ:CYTK) is one of the 13 Biotech Stocks with Huge Upside Potential. Tessa Romero, an analyst ...
Metsera Unveils First-in-Class Once-Monthly Amylin Candidate MET-233i’s Positive Phase 1 Results
Metsera, Inc. (NASDAQ:MTSR) is one of the 13 Biotech Stocks with Huge Upside Potential. Metsera, Inc. (NASDAQ:MTSR) reported ...
Is Boston losing its biotech crown? BIO conference takes place amidst industry fears
Biotechnology Innovation Organization trade show is expected to bring about 20,000 participants to Boston starting on Monday.